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ABSTRACT
Kinases form the backbone of numerous cell signal-
ing pathways, with their dysfunction similarly impli-
cated in multiple pathologies. Further facilitated by
their druggability, kinases are a major focus of thera-
peutic development efforts in diseases such as can-
cer, infectious disease and autoimmune disorders.
While their importance is clear, the role or biological
function of nearly one-third of kinases is largely un-
known. Here, we describe a data resource, the Dark
Kinase Knowledgebase (DKK; https://darkkinome.
org), that is specifically focused on providing data
and reagents for these understudied kinases to
the broader research community. Supported through
NIH’s Illuminating the Druggable Genome (IDG) Pro-
gram, the DKK is focused on data and knowledge
generation for 162 poorly studied or ‘dark’ kinases.
Types of data provided through the DKK include par-
allel reaction monitoring (PRM) peptides for quan-
titative proteomics, protein interactions, NanoBRET
reagents, and kinase-specific compounds. Higher-
level data is similarly being generated and con-
solidated such as tissue gene expression profiles
and, longer-term, functional relationships derived
through perturbation studies. Associated web tools
that help investigators interrogate both internal and
external data are also provided through the site. As
an evolving resource, the DKK seeks to continually
support and enhance knowledge on these potentially
high-impact druggable targets.
INTRODUCTION
Protein kinases take a central position in many aspects of
cellular signaling, with established roles in cellular growth,
differentiation, migration and apoptosis. With well over 500
members (1,2), kinases also represent one of the largest gene
families within humans (3,4). Likely arising from their cen-
tral role in numerous functional processes, kinase dysfunc-
tion is similarly linked to pathologies including cancer, in-
fectious disease and immune disorders. Protein kinases also
have the beneficial property of being highly druggable by
both allosteric and competitive inhibitors. This druggabil-
ity, combined with their direct or indirect role in numerous
diseases, establishes kinases as a key target for current and
future therapeutic development efforts.
Despite their recognized importance, we lack an under-
standing of the functional role of roughly one-third of ki-
nases (5). This gap in knowledge is presumably due to highly
related and potentially redundant gene function of kinase
family members, redundancy in the signaling pathways they
are part of, and tissue or developmental stage specificity.
However, recent work is now demonstrating their poten-
tial importance in multiple disease contexts (1,6–8). The po-
tential impact of better understanding these druggable and
disease-relevant targets has thus led to the establishment of
NIH’s Illuminating the Druggble Genome (IDG) Program
(9). This program seeks to establish a better understand-
ing of the function of poorly studied genes in three major,
druggable families, including GPCRs, ion channels and ki-
nases. Specifically centered on kinases, the Kinase DRGC
(Data and Resource Generating Center) component of the
IDG program is focused on generating, systematizing and
disseminating knowledge about dark kinases, the biological
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networks in which they function, and their connections to
cellular phenotypes and human disease.
As part of the Kinase DRGC effort, the Dark Kinase
Knowledgebase (DKK) is being developed to collect and
disseminate DRGC data covering the 162 kinases that have
been identified by NIH as being poorly understood or
are otherwise ‘dark kinases.’ The data being disseminated
through the DKK arise from efforts in the Kinase DRGC
focused on generating new data, both experimental and
computationally derived, that provides functional context
for each of these kinases. Combined with relevant external
data sets and cataloguing of existing resources, the Kinase
DRGC is attempting to integrate and synthesize these pri-
mary data into functional biochemical and biological in-
formation that will help researchers pursue more sophisti-
cated investigations. This support for external researchers
is, in part, being implemented through the development of
genetic and chemical tools, which are being made available
through the DKK.
Here, we describe the Dark Kinase Knowledgebase, the
initial sets of data that are being collected and presented, as
well as associated web tools that help to place these kinases
in a functional context. As the IDG Program advances and
DRGC efforts evolve, we expect the data and tools pre-
sented in the DKK to grow into a valuable resource that
supports research into these novel druggable targets with
significance in human health and disease.
MATERIALS AND METHODS
The Dark Kinase Knowledgebase uses a collection of open
source libraries and tools to both organize and display the
data sets associated with the resource.
Web and data analysis tools
The DKK server runs Red Hat Linux, with the Apache
HTTP server providing access to the web resources. On top
of Apache, incoming requests to the darkkinome.org web-
site are handled by the Dancer2 web application framework.
The search functionality uses the Text::Fuzzy Perl module
to allow for partial matching of kinase names when search-
ing the website. The content of each page served on darkki-
nome.org is stored using the Template Toolkit system and
customized depending on the types of data available for that
kinase. The D3 javascript library was used to make the bub-
ble chart displayed on the home page. The HTTPS certifi-
cate is provided by the ‘Let’s Encrypt’ service.
All of the custom figures displayed on the individual ki-
nase pages were produced using R and the ggplot plot-
ting library (10). The dark kinase expression application
was built using the R Shiny framework and served using
Shiny Server provided by R Studio. The anatogram images
showing the highlighted expression locations are built using
gganatogram (11). The source code for both the dark kinase
knowledgebase and the expression application are available
through github (see Code and Data Availability section).
DRGC data sets
The IDG-Kinase consortium is collecting several data sets
that interrogate the functions of understudied kinases.
One area where new tools are being identified by the
consortium, involves small molecule inhibitors of kinase
activity and corresponding information about the small
molecule’s activity across the entire kinome. To enable mass
spectrometry-based efforts to quantify the concentration of
dark kinases in lysate samples, the consortium is determin-
ing parallel reaction monitoring (PRM) peptides that match
with each dark kinase. The PRM peptide data set includes
the peptide associated with the kinase along with informa-
tion about the peptide’s performance in a standard curve
assay and the limit of detection for the peptide. Finally,
we have also made available a set of physical interaction
networks centered around several of the dark kinases col-
lected through affinity purification mass spectrometry. Each
of these data sets are expanding as the groups that make up
the IDG-Kinase consortium continue their efforts to test
new tools and make new data available.
All of the data sets presented in the DKK were collected
using protocols appropriate for the specific data type. The
PRM peptides were selected from unique peptides present
in each kinase and then assayed using the guidelines de-
veloped through the CPTAC consortium (12). The small
molecule inhibitor identification efforts were guided by cri-
teria developed in the inhibitor community (13). These
include broad based kinome scanning through the Ki-
nomeScan assay available through DiscoverX with promis-
ing compounds being assayed with NanoBRET probes.
We have also put detailed methods concerning NanoBRET
probe usage and associated tracer compounds on the DKK
(https://darkkinome.org/NanoBRET). The physical inter-
action networks were gathered using affinity purification
mass spectroscopy as described previously (14).
Outside data sets
Data sets from the GTex consortium (15) and the Human
Proteome Map (16) were downloaded from their respec-
tive data portals. We used the median gene-level TPM by
tissue counts provided by the GTex consortium and the
relative abundance counts provided by the Human Pro-
teome Map. We extracted the kinases from each of these
data sets and then determined, on a per tissue basis, the
relative expression of each dark kinase. For visualization,
each of the tissue types listed in the GTex consortium and
Human Proteome map were aligned to the categories pro-
vided by the gganatogram package. Data concerning can-
cer mutation, mRNA levels and copy number variations
were downloaded from the TCGA firebrowse website us-
ing the FirebrowseR package (17). We also display molec-
ular structures from PDB (18,19) that include a dark ki-
nase. These structures are displayed using the NGL viewer
(20,21).
RESULTS
The web presence for the Kinase DRGC can be divided into
two parts: the primary website at darkkinome.org and a col-
lection of standalone tools. This paper highlights the collec-
tion of resources made available through darkkinome.org
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Overall website layout
The knowledgebase is divided into several sections to sim-
plify finding and displaying the data collected through the
Kinase DRGC. These include a page detailing the data
available through the website along with links for down-
loading the data. We have also collected and provided short
descriptions of the tools that have been built by the Kinase
DRGC or have a direct connection to the website. Finally,
we also have a listing of people and publications associated
with the project. Each kinase has a page dedicated to infor-
mation about that kinase (see Sample Kinase Page Compo-
nents section) and we have also added a search function to
allow users to find a gene of interest.
These broad sections are complimented by specific pages
dedicated to listing the inhibitor tool compounds and PRM
peptides that the consortium has identified. The inhibitor
tool compounds are listed in a single table to allow quick
searching for a kinase of interest (https://darkkinome.org/
compounds). The PRM peptides and the corresponding
standard curves are also listed in a single table (https://
darkkinome.org/PRM params). Both of these data sets are
cross-referenced and displayed on the appropriate individ-
ual kinase page.
Sample kinase page components
The core of the knowledgebase is centered on providing a
single page summary for each kinase of the data and related
analyses provided by the DRGC, along with a limited set of
relevant external data (e.g. the tissue expression distribution
of the kinase as derived from GTex). The data presented on
a page varies based on the types of data the Kinase DRGC
has currently generated on that kinase and will be continu-
ally updated as data is collected. Examples of the types of
data are shown in Figure 1 and described below.
For reference, each kinase page provides an image from
CORAL (22) that shows the kinase’s position in the broader
kinase family phylogenetic tree (Figure 1A). The 162 ki-
nases under the purview of the DRGC span essentially all
branches of the kinome tree, including several atypical ki-
nases (1,24). A significant component of DRGC efforts in-
volve development of mass spectrometry resources to sup-
port quantitative proteomics. Towards these goals, mem-
bers of the DRGC are developing a set of parallel reac-
tion monitoring peptides for each kinase. These peptides,
each set of which are unique to a given kinase, enable quan-
tification of the kinase at femtomolar resolution within a
given sample. As unique peptide sequences are discovered
and validated, they are presented on the associated kinase
page along with the set calibration curves for use with mass
spectrometry (Figure 1B).
In addition to the phylogenetic tree and PRM peptides,
protein interaction networks for each kinase are also be-
ing generated, with an example being shown for PKMYT1
in Figure 1C. These networks are derived from affinity pu-
rification mass spectrometry experiments on V5-tagged ki-
nases and proximity labeling experiments using miniTurbo-
tagged kinases (14). These networks will eventually be pop-
ulated for all dark kinases. The interactive visualization
shown in Figure 1C further allow the user to modify a
few key parameters for constructing and displaying inter-
actions, and network diagrams can also be exported from
the interface. Many of the kinase pages (∼30 kinases to
date) also have summaries of characterized chemical tool
inhibitor compounds (Figure 1D). The chemical tool sum-
mary section displays several key properties of the identified
compounds as well as links to learn more about the com-
pound’s inhibition properties and purchase the compound.
A number of other databases have highly relevant and
complementary information about a given kinase, and so
for each kinase we have outgoing links to resources in-
cluding Pharos (https://pharos.nih.gov/) (25), Gene Cards
(https://www.genecards.org/) (26) and the Monarch Initia-
tive (https://monarchinitiative.org/) (27). We have similarly
summarized TCGA data for each kinase through heatmaps
that provide a visualization on mutations, copy number
variation and mRNA expression levels of the kinase across
multiple cancer types. We are further providing functional
interaction networks for each dark kinase, for example us-
ing data integrated through INDRA (1,28,29). A summary
of the highlights from our Dark Kinase expression browser
(described further below) is also displayed with correspond-
ing links to the full application. As data specific to each un-
derstudied kinase is generated by the Kinase DRGC, kinase
pages will be updated and further integrated with relevant
external data sets.
DKK expression browser
A common question we receive involves the question of
where in the human body a given dark kinase is expressed.
To help answer this question we integrated results from two
comprehensive surveys of human tissues from the GTex
consortium (15) and the Human Proteome Map (16). Using
these two data sources we collected the RNAseq summary
counts from GTex and the mass spectrometry-based survey
of human protein abundance. As our focus is on placing
the dark kinases into context with the rest of the kinome,
we have filtered these datasets to only include kinases. This
focus on kinases allows the user to compare the expression
profile of a given understudied kinase in relation to other ki-
nases that are often much better characterized. In addition,
we have further contextualized measurements by convert-
ing the total read counts or mass spectrometry abundance
values for all kinases into a percentile on an organ-by-organ
basis (Figure 2). Using these kinome-specific data sets, we
have produced an interactive data browser available through
the web (http://expression.darkkinome.org/).
The browser was developed using the R shiny framework
(30) and allows the user to select any of the 162 dark kinases
via a dropdown menu in the upper left corner. There is also a
slider to set the minimum kinase percentile displayed. When
the percentile value is changed, the anatograms and the data
table update to reflect this new threshold. The plot next to
the anatograms displays the expression percentiles of the se-
lected kinase with a bold line, while the remaining gray lines
show the kinase expression percentiles for all remaining ki-
nases. To further enable comparisons with the rest of the
kinome, we have also calculated the correlation between ki-
nases across organs and show the five most well correlated
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Figure 1. Several types of data related to dark kinases are displayed on the individual kinase pages. (A) Kinase tree showing the location of PKMYT1 in the
canonical kinase phylogenetic tree (3) produced using CORAL (22). (B) Calibration curve related to a PRM peptide related to PKMYT1. (C) Interactive
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Figure 2. Sample screenshot from the Dark Kinase Expression browser (http://expression.darkkinome.org) with MKNK2 selected. Individual sections of
the page are highlighted with colored boxes and associated labels. Along the top edge is a tabbed interface for selecting methods of browsing (either by
kinase or organ system) and the type of data (GTex Consortium or Human Protein Atlas). The colors in the anatogram figures only mark the organs
expressing the selected kinase.
selection dropdown box is show in rank order of the highest
average organ percentile, so the kinases highest on the list
are the most expressed with those at the bottom of the list
being the least expressed. MKNK2 has the highest average
expression by this metric, while PSKH2 has the lowest. The
data contributing to these results are displayed in a data ta-
ble underneath these elements with a link to download the
filtered data set in CSV format. These interface elements are
replicated in the other tabs along the top of the page.
In addition to the kinase-centric view displayed on the
first page, we have also created organ-centric views of this
same data. This view of the data is most useful for re-
searchers interested in a specific organ system and who
would like to view the dark kinases with the highest expres-
sion in that organ. None of the organ systems show dramati-
cally different expression variation between overall dark ki-
nase expression profiles. Within this range of organ varia-
tion though, the brain regions make up most of the organ
systems with higher dark kinase expression levels. We hope
this tool will allow researchers to answer questions about
the presence of dark kinases and their relation to other well-
studied kinases at the organ level.
Additional web-based tools
In addition to the Dark Kinome Expression Browser, sev-
eral affiliated tools have also been developed by the Kinase
DRGC and collaborators. These tools include:
• Visualization methods specific to the kinome (CORAL,
Figure 3A) (22)
• Kinase targets in cancer (the Clinical Kinase Index, Fig-
ure 3B) (31)
• Biological pathways that include dark kinases and other
understudied proteins (IDG Reactome, Figure 3C) (32)
• Collections of small molecule kinase inhibitors (Small
Molecule Suite, Figure 3D) (33)
Each of these tools provide a unique set of methods and
data concerning the role of understudied kinases in a range
of biological contexts.
Code and Data Availability
All of the computer code associated with the Dark Ki-
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Figure 3. Several tools affiliated with the Dark Kinase Knowledgebase. (A) CORAL: the kinase tree visualization tool. (B) The Clinical Kinase Index,
which focuses on the kinase’s role in cancer. (C) The IDG Reactome portal provides a window into the Reactome database centered around understudied
genes. (D) The Small Molecule Suite toolkit for selection of kinase inhibitors
//github.com/IDG-Kinase/darkkinasekb), as is the code
underlying the kinase expression browser (https://github.
com/IDG-Kinase/kinase expression). In addition to these
two projects, related code produced by the consor-
tium is listed on our github group page (https://github.
com/IDG-Kinase). We also maintain a collection of
data through Synapse (https://www.synapse.org/#!Synapse:
syn18360482/files/) for the distribution of bulk data sets and
those data types lacking standard public repositories.
CONCLUSION AND FUTURE DIRECTIONS
The Dark Kinase Knowledgebase provides a collection of
resources dedicated to improving our understanding of un-
derstudied kinases. Data underlying the DKK is derived
from both experimental and computational efforts within
the Kinase DRGC as well as publicly-available external data
sets. A kinase-centric view provides each understudied ki-
nase with a page dedicated to rapidly presenting informa-
tion relevant to understanding potential function or to tools
that can be used to experimentally investigate behavior.
Similarly, associated tools such as the expression browser,
place understudied kinases in the context of more well-
studied kinases, further enhancing potential understanding
of downstream function.
The DKK is a young and still growing resource. Ongoing
Kinase DRGC efforts are focused on expanding the vari-
ous data types, including chemical tools, physical and func-
tional interaction networks, and PRM peptides, across all
understudied kinases. Also, relevant external data sets will
continue to be incorporated, providing an integrated pic-
ture of the current state of knowledge surrounding a par-
ticular target kinase. In addition to these data, we will fur-
ther explore the development of associated web applica-
tions, similar to the expression browser, that leverage these
underlying data and enable further insight into kinase func-
tion. We are also working to integrate our results with out-
side tools such as KinView (34). Beyond the currently rep-
resented data types, the Kinase DRGC is actively generat-
ing several types of data not currently represented on the
website. For example, one such data set will detail the tran-
scriptional changes in response to treatment with kinase in-
hibitors, and how these changes then modify the activities
of the entire kinome. Another set of DRGC work focuses
on developing and applying a novel collection of machine
learning algorithms to investigate and potentially predict
new small molecules capable of inhibiting kinases.
By integrating both DRGC generated data along with
external data sets, the DKK is designed to help provide
researchers with a concise view of the state of knowledge
surrounding a given kinase. Similarly, the dissemination of
DRGC relevant tools such as PRM peptides and associ-
ated calibration curves to the broader research commu-
nity is a crucial goal of both the DKK and the broader
IDG Consortium. As more data is generated and synthe-
sized, we hope the DKK can provide greater insight into the
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